BHVN Q4 2025 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$143M

Net Income

-$146M

EPS (Diluted)

$-1.21

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$131M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$451M

Total Liabilities

$399M

Stockholders' Equity

$52M

Cash & Equivalents

$230M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$143M	-$190M	+24.8%
Net Income	-$146M	-$187M	+22.1%